ATE406903T1 - Zusammensetzung und ihre verwendungszwecke zur bekämpfung von kater - Google Patents

Zusammensetzung und ihre verwendungszwecke zur bekämpfung von kater

Info

Publication number
ATE406903T1
ATE406903T1 AT02748426T AT02748426T ATE406903T1 AT E406903 T1 ATE406903 T1 AT E406903T1 AT 02748426 T AT02748426 T AT 02748426T AT 02748426 T AT02748426 T AT 02748426T AT E406903 T1 ATE406903 T1 AT E406903T1
Authority
AT
Austria
Prior art keywords
composition
hangover
fighting
fructose
exacerbated
Prior art date
Application number
AT02748426T
Other languages
English (en)
Inventor
Neil Mcgregor
Original Assignee
Penam Invest Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penam Invest Pty Ltd filed Critical Penam Invest Pty Ltd
Application granted granted Critical
Publication of ATE406903T1 publication Critical patent/ATE406903T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Table Devices Or Equipment (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT02748426T 2001-07-10 2002-07-05 Zusammensetzung und ihre verwendungszwecke zur bekämpfung von kater ATE406903T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR6261A AUPR626101A0 (en) 2001-07-10 2001-07-10 A composition and uses therefor

Publications (1)

Publication Number Publication Date
ATE406903T1 true ATE406903T1 (de) 2008-09-15

Family

ID=3830225

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02748426T ATE406903T1 (de) 2001-07-10 2002-07-05 Zusammensetzung und ihre verwendungszwecke zur bekämpfung von kater

Country Status (9)

Country Link
US (1) US7449448B2 (de)
EP (1) EP1411879B1 (de)
JP (1) JP2004534094A (de)
AT (1) ATE406903T1 (de)
AU (2) AUPR626101A0 (de)
CA (1) CA2453159A1 (de)
DE (1) DE60228722D1 (de)
WO (1) WO2003006073A1 (de)
ZA (1) ZA200400165B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077464A1 (en) * 2004-02-17 2005-08-25 Matuschka-Greinffenclau Markus Alcohol metabolism moderating composition
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
DK1909600T3 (da) * 2005-07-29 2012-07-30 Tima Foundation Sammensætning til moderering af alkoholmetabolisme og til at reducere risikoen for alkoholforårsagede sygdomme
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016955A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Alcohol metabolism moderating composition
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
WO2007032340A1 (ja) * 2005-09-12 2007-03-22 Kyowa Hakko Kogyo Co., Ltd. α－リポ酸含有組成物
US8633192B2 (en) 2006-12-15 2014-01-21 Tima Foundation Compositions and uses thereof
RU2358723C1 (ru) * 2008-01-31 2009-06-20 Андрей Александрович Иващенко Средство, обладающее антипохмельным действием, биологически активная добавка, фармацевтическая композиция, лекарственное средство и способ получения
RU2396076C1 (ru) * 2009-01-29 2010-08-10 Андрей Александрович Иващенко Средство, уменьшающее степень острой алкогольной интоксикации (опьянения) и обладающее антипохмельным действием, биологически активная добавка, фармацевтическая композиция, лекарственное средство и способ получения
US9474802B2 (en) 2010-10-28 2016-10-25 Jonathan Burg Compositions and methods to reduce hangover and reduce blood alcohol levels after alcohol consumption
DE102011013224A1 (de) 2011-03-07 2012-09-13 Roman Gerdes Orthomolekulares Mittel gegen die Folgen von Alkoholkonsum
WO2013072441A1 (en) 2011-11-15 2013-05-23 Tima Foundation Composition for protection against cell-damaging effects
WO2013136349A1 (en) * 2012-03-14 2013-09-19 Biffi-Helps S.R.L. Digestion adjuvant compound
US9622999B2 (en) * 2013-11-06 2017-04-18 Salim JARROUJ Composition and method for increasing the rate of alcohol metabolism and preventing hangover symptoms
US10413563B2 (en) * 2017-05-10 2019-09-17 Emerald Neuro-Recover, LLC Neurochemical wellness program
US20230037437A1 (en) * 2019-12-18 2023-02-09 Unibiolabs Internacional S.A De C.V Formulations for use in the treatment of different types of addictions and dependence on addictive substances

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496548A (en) * 1983-02-04 1985-01-29 Moldowan Mervin J Composition and method for reducing hangover
EP0185117A1 (de) * 1984-12-21 1986-06-25 IPEX Getränke-Herstellungs- und Vertriebsgesellschaft mbH Getränk
RU2086237C1 (ru) * 1994-12-05 1997-08-10 Олег Николаевич Немировский Средство для купирования алкогольного абстинентного синдрома
GB9526741D0 (en) 1995-12-30 1996-02-28 Sobering Thoughts Ltd Product for combatting dehydration
FR2748935A1 (fr) * 1996-05-23 1997-11-28 Clergeaud Jean Solution buvable favorisant la baisse du taux d'alcoolemie
GB9725061D0 (en) 1997-11-27 1998-01-28 Tagg Npd Limited Revitalisation formulation
RU2160589C1 (ru) * 2000-05-18 2000-12-20 Алекс Кашлинский Средство для снижения алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома и способ снижения алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома с использованием этого средства

Also Published As

Publication number Publication date
DE60228722D1 (de) 2008-10-16
ZA200400165B (en) 2004-11-01
US20040248819A1 (en) 2004-12-09
WO2003006073A1 (en) 2003-01-23
US7449448B2 (en) 2008-11-11
AU2002318969B2 (en) 2005-11-03
CA2453159A1 (en) 2003-01-23
JP2004534094A (ja) 2004-11-11
AUPR626101A0 (en) 2001-08-02
EP1411879A4 (de) 2005-06-22
EP1411879B1 (de) 2008-09-03
EP1411879A1 (de) 2004-04-28

Similar Documents

Publication Publication Date Title
DE60228722D1 (de) Zusammensetzung und ihre verwendungszwecke zur bekämpfung von kater
CA2331395A1 (en) Fatty acid analogues for the treatment of diabetes
EP1796669A4 (de) Aminopiperidine als dipeptidylpeptidase-iv-inhibitoren zur behandlung oder prävention von diabetes
ATE462427T1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
BR0207420A (pt) Processo e composições para desinfecção de superfìcies duras
ATE292460T1 (de) Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels
EA200870019A1 (ru) Лактамовые соединения и способы их применения
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
EP1554256A4 (de) Piperidinopyrimidindipeptidylpeptidaseinhibitoren zur behandlung von diabetes
EP1888066A4 (de) Aminocyclohexane als dipeptidylpeptidase-iv-hemmer zur behandlung bzw. prävention von diabetes
EP1385508A4 (de) Dipeptidylpeptidase-hemmer für die behandlung oder prävention von diabetes
ATE458057T1 (de) Varianten der faktor-vii- oder -viia-gla-domäne
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
BR9916270A (pt) Combinação de cerivastatina e fibratos
IS2517B (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
GB0111186D0 (en) Novel compounds
ATE396697T1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
DE60316010D1 (de) Neue kristalline hydrate des natriumsalzes der 3-pyridyl-1-hydroxyethyliden-1-bisphosphonsäure
DE602005024546D1 (de) System zur bewertung des ph-werts und der pufferkapazität von feuchtigkeit enthaltenden reinigungsartikeln
MY147371A (en) Composition containing oligosaccharides for the treatment / prevention of infections
ATE423102T1 (de) 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer
HUP0301864A2 (hu) Fenoláttartalmú, alacsony fagyáspontú készítmény

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties